Cargando…
Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented
BACKGROUND: Available literature concerning the epidemiologic or clinical features of vulvovaginal candidiasis commonly reports that: 75% of women will experience an episode of vulvovaginal candidiasis in their lifetimes, 50% of whom will experience at least a second episode, and 5-10% of all women...
Autores principales: | Rathod, Sujit D, Buffler, Patricia A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975582/ https://www.ncbi.nlm.nih.gov/pubmed/24612727 http://dx.doi.org/10.1186/1472-6874-14-43 |
Ejemplares similares
-
Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
por: Ge, Gai, et al.
Publicado: (2022) -
Epidemiologic Features of Vulvovaginal Candidiasis among Reproductive-Age Women in India
por: Rathod, Sujit D., et al.
Publicado: (2012) -
Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
por: Rosati, Diletta, et al.
Publicado: (2020) -
Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
por: Grant, Leah M., et al.
Publicado: (2022) -
Insights and advances in recurrent vulvovaginal candidiasis
por: San Juan Galán, Javier, et al.
Publicado: (2023)